NEW YORK (Reuters) - Proxy advisory firm Glass Lewis recommends that Masimo shareholders elect activist investor Politan's two proposed candidates to the medical device maker's five-member board, according to a report reviewed by Reuters. "We believe investors should endorse the election of (William) Jellison and (Darlene) Solomon at this time," the report said, arguing the current board is to blame for failures at the company, including its tumbling stock price. "The existing board remains obdurately committed to legacy oversight methodologies which have consistently enabled and amplified poor governance architecture, wide operational misses, nil-return strategic excursions, seemingly de minimis accountability and, ultimately, a lax commitment to acknowledging and addressing profound damage to shareholder value," the report said. This marks the second time in two years that Politan has proposed board candidates. Last year shareholders elected its two suggested directors, including the firm's founder, hedge fund manager Quentin Koffey. ADVERTISEMENT Masimo's stock price has tumbled 24% over the last 52 weeks. Glass Lewis and its bigger rival Institutional Shareholder Services influence how investors vote on critical issues including proposed mergers and who sits on the board with their recommendations. ISS has not yet issued its report on Masimo. Shareholders will vote on July 25 unless the two sides find a compromise beforehand. (Reporting by Svea Herbst-Bayliss; Editing by David Holmes)
Glass Lewis recommends Masimo investors elect Politan candidates to board
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...